Portal de Periódicos da CAPES

Eosinophils and primary biliary cirrhosis?Stoking the fire?

1999; Lippincott Williams & Wilkins; Volume: 30; Issue: 1 Linguagem: Inglês

10.1002/hep.510300150

1527-3350

James Neuberger,

Eosinophilic Disorders and Syndromes

HepatologyVolume 30, Issue 1 p. 335-337 EditorialFree Access Eosinophils and primary biliary cirrhosis—Stoking the fire? James Neuberger M.D., Corresponding Author James Neuberger M.D. M.D. From the Liver Unit, Queen Elizabeth Hospital, Birmingham, UKThe Liver and Hepatobiliary Unit, 3rd Floor, Nuffield House, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, fax: (44) 121 627 2449===Search for more papers by this author James Neuberger M.D., Corresponding Author James Neuberger M.D. M.D. From the Liver Unit, Queen Elizabeth Hospital, Birmingham, UKThe Liver and Hepatobiliary Unit, 3rd Floor, Nuffield House, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, fax: (44) 121 627 2449===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/hep.510300150Citations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996; 98: 371– 381. MEDLINE 2 Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Res 1986; 85: 422– 456. 3 Rochester CL, Ackerman SJ, Zheng T, Elias JA. Eosinophil-fibroblast interactions. J Immunol 1996; 156: 4449– 4456. MEDLINE 4 Kokubin M, Kuroda M, Takagi T, Saito K, Nishimaki T, Morito T, Kasukawa R. Eosinophilia in primary biliary cirrhosis. Nippon Shokakibyo Gakkai Zasshi 1990; 87: 1410– 1416. MEDLINE 5 Wirth HP, Meyenberger C, Altorfer J, Ammann R, Blum HE. Eosinphilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid. Schweiz Med Wochenschr 1994; 124: 810– 815. MEDLINE 6 Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91: 516– 522. MEDLINE 7 Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinphilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 1993; 17: 206– 212. MEDLINE 8 Nakamura A, Yamazaki K, Suzuki K, Sato S. Increased portal tract infiltrate of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 1997; 92: 2245– 2249. MEDLINE 9 Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5 and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996; 80: 311– 320. MEDLINE 10 Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181: 723– 733. MEDLINE 11 Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113– 119. MEDLINE 12 Harada K, Van de Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25: 791– 796. MEDLINE 13 Shindo M, Mullin GE, Braun-Elert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 1996; 105: 254– 259. MEDLINE 14 Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Lohr HF, Meyer zum Buschenfelde KH. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431: 119– 124. MEDLINE 15 Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 115– 123. MEDLINE 16 Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol 1998; 161: 4340– 4346. MEDLINE 17 Ohashi H, Takei M, Ide Y, Ishii H, Kita H, Gleich GJ, Ishikawa M, et al. Effect of interleukin-3, interleukin 5 and hyaluronic acid on cultured eosinophils derived from human umbilical cord blood mononuclear cells. Int Arch Allergy Immunol 1999; 118: 44– 50. MEDLINE 18 Gharib B, Abdallahi OM, Dessein H, de Reggi M. Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice affected with Schistosoma mansoni. J Hepatol 1999; 30: 594– 602. MEDLINE 19 Goulis J, Leandro G, Burroughs AK. No evidence for ursodeoxycholic (UDCA) therapy in primary biliary cirrhosis (PBC): a meta-analysis [Abstract]. J Hepatol 1999; 30(Suppl 1): 57. 20 Gluud C, Christensen E. Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC)—a Cochrane hepatobiliary systematic review [Abstract]. J Hepatol 1999; 30(Suppl 1): 83. 21 Neuberger J. Primary biliary cirrhosis. Lancet 1997; 350: 875– 879. MEDLINE 22 Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, Tarara JE, et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 1999; 30: 71– 78. MEDLINE 23 Stiehl A, Benz C, Sauer P. Mechanism of hepatoprotective action of bile salts in liver disease. Gastroenterol Clinics North Am 1999; 28: 195– 209. 24 Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, et al. Immunomodulatory effects of ursodeoxycholic acid on immune resposes. Hepatology 1992; 16: 358– 364. MEDLINE 25 Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 1992; 103: 617– 621. MEDLINE 26 Calmus Y, Podevin P, Robert A, Poupon R. Differential effects of chenodeoxycholic and ursodeoxycholic acids on expression of procoagulant activity by human monocytes. J Hepatol 1994; 20: 466– 472. MEDLINE 27 Hattori Y, Murakami Y, Hattori S, Kuroda H, Kasai K, Shimoda S. Ursodeoxycholic acid inhibits the induction of nitric oxide synthase. Eur J Pharmacol 1996; 300: 147– 150. MEDLINE 28 Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger J. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998; 352: 1595– 1596. MEDLINE 29 Sanders SP. Asthma, viruses and nitric oxide. Proc Soc Exp Biol Med 1999; 220: 123– 132. MEDLINE 30 Quist RG, Ton-Nu HT, Lillienau J, Hofmann AF, Barrett KE. Activation of mast cells by bile acids. Gastroenterology 1991; 101: 446– 456. MEDLINE 31 Lacaille F, Paradis K. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993; 18: 165– 172. MEDLINE 32 Nishigaki Y, Ohnishi H, Moriwaki H, Muto Y. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. Dig Dis Sci 1996; 41: 1487– 1493. MEDLINE 33 Bergamini A, Dini L, Baiocchi L, Cappannoli L, Falasca L, Bolacchi F, Capozza M, et al. Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells. Hepatology 1997; 25: 927– 933. MEDLINE 34 Khan KN, Tsutumi T, Nakata K, Nakao K, Kato Y, Nagataki S. Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids. J Gastroenterol Hepatol 1998; 13: 643– 650. MEDLINE 35 Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullal-Ublick GA, Sauter G, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996; 110: 1553– 1563. MEDLINE 36 Matsuzaki Y, Bouscarel B, Le M, Ceryak S, Gettys TW, Shoda J, Fromm H. Effect of cholestasis on regulation of cAMP synthesis by glucagon and bile acids in isolated hepatocytes. Am J Physiol 1997; 273: G164– G174. MEDLINE 37 Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, Dransfield I, et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leucocytes. J Immunol 1999; 162: 3639– 3646. MEDLINE 38 Matsukura M, Yamada H, Yudate T, Tezuka T, Chihara J. Corticosteroid-induced apoptosis of eosinophils in atopic dermatitis patients. J Clin Lab Immunol 1996; 48: 109– 122. MEDLINE 39 Mitchison HC, Palmer JM, Bassendine M, Watson AJ, Record CO, James OFW. A controlled trial of prednisolone treatment in primary biliary cirrhosis. J Hepatol 1992; 15: 336– 344. MEDLINE 40 Tanaka H, Makino Y, Miura T, Hirano F, Okamoto K, Komura K, Sato Y, et al. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. J Immunol 1996; 156: 1601– 1608. MEDLINE 41 Meng Q, Ying S, Corrigan CJ, Wakelin M, Assoufi B, Moqbel R, Kay AB. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Allergy 1997; 52: 1095– 1101. MEDLINE 42 Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, Ring Larsen H, et al. Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 1993; 104: 519– 526. MEDLINE 43 Miyaguchi S, Oda M, Saito H, Ishii H. Novel therapeutic approach to primary biliary cirrhosis: anti-eosinophil strategy. Hepatogastroenterology 1998; 45: 1457– 1461. MEDLINE 44 Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K. Fourteen member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother 1999; 43: 907– 911. MEDLINE Citing Literature Volume30, Issue1July 1999Pages 335-337 ReferencesRelatedInformation